Danish pharmaceutical company Lundbeck made an undisclosed milestone payment to biotech Ossianix Inc., after experiments showed that shark antibodies effectively shuttled potential drugs across the blood-brain barrier in mice.
The 2 companies established a research collaboration in 2014, focusing on technology development and the delivery of antibody-based therapies across the blood-brain barrier.
Get the full story at our sister site, Drug Delivery Business News.
The post Early research shows shark antibodies carrying drugs across blood-brain barrier appeared first on MassDevice.
from MassDevice http://ift.tt/2kjKGRf
Cap comentari:
Publica un comentari a l'entrada